Clinical & Experimental Cardiology
Open Access

Hydroxchloroquine cardiomyopathy: An insight into a rare disease

6^th International Conference on Clinical & Experimental Cardiology

November 30-December 02, 2015 San Antonio, USA

Mohamed A Ahmed

University Hospital Limerick, Ireland

Posters-Accepted Abstracts: J Clin Exp Cardiolog

Abstract :

Hydroxy Chloro Quine (HCQ) is an antimalarial drugs that has been used for treatment of connective tissue disorders. Unlike other agents, Hydroxychloroquine has gained popularity because of its relatively safe profile and less toxic side effects. Hydroxychloroquine cardiotoxicity is a rare disease but a potentially fatal heart condition. To date, no clear guidelines or protocols exist to monitor patients for development of the cardiac side effect of HCQ. In this brief review we will focus on Hydroxychloroquine Cardiotoxicity, its clinical presentation, diagnosis,potential risk factors that are predisposing to the cardiomyopathy and variables that affect the outcome of this rare for of cardiomyopathy.

Biography :

Email: mod3llam@live.com